MoneyWorks4Me

Glaxosmithkline Pharmaceuticals informs about compliances-certificate

02 Apr 2024 Evaluate
In Compliance with Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, Glaxosmithkline Pharmaceuticals has enclosed a copy of the Certificate received from Kfin Technologies, the Registrar and share Transfer Agent of the Company, for the quarter ended 31st March 2024.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1852.50
Dr. Reddys Labs. 1146.30
Cipla 1360.10
Lupin 2047.00
Zydus Lifesciences 1108.50
View more..